Warwick J Britton
Overview
Explore the profile of Warwick J Britton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
4404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quan D, Wang T, Martinez E, Kim H, Sintchenko V, Britton W, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Mar;
PMID: 40048098
The significant global impact of tuberculosis (TB) on human health is exacerbated by the increasing prevalence of multi-drug resistant tuberculosis (MDR-TB) and the challenges of novel drug discovery for the...
2.
Lukeman H, Al-Wassiti H, Fabb S, Lim L, Wang T, Britton W, et al.
EBioMedicine
. 2025 Feb;
113:105599.
PMID: 39955975
Background: Mycobacterium tuberculosis remains the largest infectious cause of mortality worldwide, even with over a century of widespread administration of the only licenced tuberculosis (TB) vaccine, Bacillus Calmette-Guérin (BCG). mRNA...
3.
Stevens M, Hawkins P, Wang T, Payne R, Britton W
Tuberculosis (Edinb)
. 2025 Jan;
151:102594.
PMID: 39756243
Multi-drug-resistant Mycobacterium tuberculosis is an escalating global health problem, and a strong pipeline of novel compounds is needed to combat rising antimicrobial resistance. Ecumicin is a novel analogue of the...
4.
Bedding M, Forster B, Giltrap A, Stevens M, Corcilius L, Britton W, et al.
Org Lett
. 2024 Dec;
26(50):10993-10998.
PMID: 39653016
The rufomycins are a family of nonribosomal cyclic peptides isolated from the deep sea-dwelling Herein, we describe the total synthesis of six congeners in the rufomycin family. Synthesis was achieved...
5.
Shrestha L, Tungatt K, Aggarwal A, Stubis A, Fewings N, Fichter C, et al.
EBioMedicine
. 2024 Nov;
110:105461.
PMID: 39612651
Background: Current literature informs us that bivalent vaccines will generate a broader serum neutralizing antibody response to multiple SARS-CoV-2 variants, but studies on how this breadth relates to the memory...
6.
Quan D, Wang T, Martinez E, Kim H, Sintchenko V, Britton W, et al.
J Appl Microbiol
. 2024 Oct;
135(10).
PMID: 39394664
Background: The enormous burden of tuberculosis (TB) worldwide is a major challenge to human health, but the costs and risks associated with novel drug discovery have limited treatment options for...
7.
Nisa A, Pinto R, Britton W, Triccas J, Counoupas C
Vaccines (Basel)
. 2024 Sep;
12(9).
PMID: 39340027
There is an urgent need for an effective TB vaccine capable of controlling both acute and chronic infection in populations with diverse genetic backgrounds. In this study, we characterised the...
8.
Torres-Robles A, Baysari M, Allison K, Shaw M, Hutchings O, Britton W, et al.
Digit Health
. 2024 Sep;
10:20552076241269513.
PMID: 39291153
Objective: This study aims to develop a measurement model for health technology acceptability using a theoretical framework and a range of validated instruments to measure user experience, acceptance, usability, health...
9.
Maxwell J, Stockdale S, Stewart E, Ashley C, Smith L, Steain M, et al.
ACS Infect Dis
. 2024 Aug;
10(9):3419-3429.
PMID: 39196071
Despite concerted efforts to tackle the COVID-19 pandemic, the persistent transmission of SARS-CoV-2 demands continued research into novel vaccination strategies to combat the virus. In light of this, intranasally administered...
10.
Stewart E, Counoupas C, Steain M, Ashley C, Alca S, Hartley-Tassell L, et al.
Immunol Cell Biol
. 2024 May;
102(7):593-604.
PMID: 38757764
Delta inulin, or Advax, is a polysaccharide vaccine adjuvant that significantly enhances vaccine-mediated immune responses against multiple pathogens and was recently licensed for use in the coronavirus disease 2019 (COVID-19)...